Geneyork Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GENEYORK PHARMS, and what generic and branded alternatives to GENEYORK PHARMS drugs are available?
GENEYORK PHARMS has five approved drugs.
Drugs and US Patents for Geneyork Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Geneyork Pharms | PREDNISONE | prednisone | TABLET;ORAL | 210525-002 | Dec 4, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Geneyork Pharms | PREDNISONE | prednisone | TABLET;ORAL | 210525-001 | Dec 4, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Geneyork Pharms | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 214890-001 | Jul 7, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.